Additionally, by analyzing the tumor-produced factors which induce suppressive CD33+ cells from PBMC, Lechner et al. (35) demonstrated that the combination of GM-CSF and IL-6 is more potent than the combination of GM-CSF and other mediators, such as PGE2. The gene discussed is IL6; the disease is neoplasm.